{"id":1778,"date":"2010-09-02T14:46:46","date_gmt":"2010-09-02T18:46:46","guid":{"rendered":"https:\/\/www.bumc.bu.edu\/busm-pathology\/?page_id=1778"},"modified":"2015-06-03T11:30:55","modified_gmt":"2015-06-03T15:30:55","slug":"john-meyers-phd","status":"publish","type":"page","link":"https:\/\/www.bumc.bu.edu\/busm-pathology\/home\/people_main\/john-meyers-phd\/","title":{"rendered":"John Meyers, PhD"},"content":{"rendered":"<p><a href=\"\/busm-pathology\/files\/2008\/11\/jmeyers.jpg\"><img loading=\"lazy\" class=\"alignnone size-full wp-image-601\" title=\"jmeyers\" src=\"\/busm-pathology\/files\/2008\/11\/jmeyers.jpg\" alt=\"jmeyers\" width=\"108\" height=\"153\" \/><\/a><br \/>\nDEFENDED Summer 2009<\/p>\n<h3>EDUCATION<\/h3>\n<ul>\n<li>2010\u00a0\u00a0 \u00a0PhD Program \u2013 Department of Pathology and Laboratory Medicine<br \/>\nBoston University School of Medicine, Boston, MA<br \/>\nDr. Adam Lerner Lab \u2013 Advisor:<br \/>\nThesis Title: Unique Cyclic Nucleotide Signaling in Chronic Lymphocytic Leukemia Represents a Potential Novel Therapeutic Target.<\/li>\n<li>2005:\u00a0\u00a0\u00a0 M.A. &#8211;\u00a0 Boston University School of Medicine<br \/>\nThesis Title: The Effects of Continuous Type I Interferon Exposure On T Helper Cell\u00a0 Responses<\/li>\n<li>2002:\u00a0\u00a0\u00a0 A.B.\u00a0 Biochemistry with Honors; Minor, Computer Scienc<br \/>\nThesis Title:\u00a0 The Immunology of Natural Parasite Resistance in Sheep: An Honors Paper for the Program of Biochemistry<br \/>\nBowdoin College, Brunswick, ME<\/li>\n<\/ul>\n<h3>PUBLICATIONS<\/h3>\n<ul>\n<li><strong>Meyers JA<\/strong>, Su DW, Lerner A.\u00a0 CLL, B and T cells differ in their response to cyclic nucleotide phosphodiesterase inhibitors. J. Immunol.; 2009; 182: 5400 &#8211; 5411<\/li>\n<li><strong>Meyers JA<\/strong>, Taverna J, Chaves J, Makkinje A, Lerner A.\u00a0 PDE4 inhibitors augment levels of glucocorticoid receptor in B cell chronic lymphocytic leukemia but not in normal circulating hematopoietic cells.\u00a0 Clin. Cancer Res.;\u00a0 2007: 13:4920-4927<\/li>\n<li> Mineva ND, Rothstein TL, <strong>Meyers JA<\/strong>, Lerner A, Sonenshein GE. CD40 ligand mediated activation of the de novo RelB NF-kappa B synthesis pathway in transformed B cells promotes rescue from apoptosis. J Biol Chem. 2007.<\/li>\n<li>Everett PC, <strong>Meyers JA,<\/strong> Makkinje A, Rabbi M, Lerner A. Preclinical assessment of curcumin as a potential therapy for B-CLL. Am J Hematol. 2007;82:23-30.<\/li>\n<li>Alyson J. Mangini, <strong>John A. Meyers<\/strong>, Taro Nagai, Gijs van Seventer, and Jean Maguire van Seventer. Type I interferon regulation of Th cell responses in SLE. J. Immunol., 2007; 178: B84<\/li>\n<li><strong>Meyers JA<\/strong>, Mangini AJ, Nagai T, et al. Blockade of TLR9 agonist-induced type I interferons promotes inflammatory cytokine IFN-gamma and IL-17 secretion by activated human PBMC. Cytokine. 2006;35:235-246.<\/li>\n<li> Ronald L. Christensen, Arij Faksh, <strong>John A. Meyers<\/strong>, Ifor D. W. Samuel, Phillip Wood, Richard R. Schrock, and Kai C. Hultzsch. Optical Spectroscopy of Long Polyenes. J. Phys. Chem. A; 2004; 108(40) pp 8229 \u2013 8236<\/li>\n<\/ul>\n<h3>MEMBERSHIPS<\/h3>\n<ul>\n<li>American Association of Immunologists (AAI)<\/li>\n<li>American Association for the Advancement of Science<\/li>\n<\/ul>\n<h3>APPOINTMENTS<\/h3>\n<ul>\n<li>Predoctoral Trainee 2006-2009<br \/>\nHematology Training Program (NIH Grant #T32 HL007501)<br \/>\nBoston University School of Medicine, Boston MA<br \/>\nAdam Lerner MD, Program Director<\/li>\n<li>Henry I. Russek Student Achievement Award<br \/>\nFirst Prize 2009<br \/>\nDivision of Graduate Medical Sciences<br \/>\nBoston University School of Medicine<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>DEFENDED Summer 2009 EDUCATION 2010\u00a0\u00a0 \u00a0PhD Program \u2013 Department of Pathology and Laboratory Medicine Boston University School of Medicine, Boston, MA Dr. Adam Lerner Lab \u2013 Advisor: Thesis Title: Unique Cyclic Nucleotide Signaling in Chronic Lymphocytic Leukemia Represents a Potential Novel Therapeutic Target. 2005:\u00a0\u00a0\u00a0 M.A. &#8211;\u00a0 Boston University School of Medicine Thesis Title: The Effects [&hellip;]<\/p>\n","protected":false},"author":1131,"featured_media":0,"parent":3281,"menu_order":93,"comment_status":"closed","ping_status":"open","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/www.bumc.bu.edu\/busm-pathology\/wp-json\/wp\/v2\/pages\/1778"}],"collection":[{"href":"https:\/\/www.bumc.bu.edu\/busm-pathology\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.bumc.bu.edu\/busm-pathology\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/busm-pathology\/wp-json\/wp\/v2\/users\/1131"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/busm-pathology\/wp-json\/wp\/v2\/comments?post=1778"}],"version-history":[{"count":4,"href":"https:\/\/www.bumc.bu.edu\/busm-pathology\/wp-json\/wp\/v2\/pages\/1778\/revisions"}],"predecessor-version":[{"id":10469,"href":"https:\/\/www.bumc.bu.edu\/busm-pathology\/wp-json\/wp\/v2\/pages\/1778\/revisions\/10469"}],"up":[{"embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/busm-pathology\/wp-json\/wp\/v2\/pages\/3281"}],"wp:attachment":[{"href":"https:\/\/www.bumc.bu.edu\/busm-pathology\/wp-json\/wp\/v2\/media?parent=1778"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}